CVS Health (NYSE: CVS) saw its net income expand by $4.2 billion or 101% y-o-y to $8.3 billion in 2023. This can primarily be attributed to the opioid litigation charges included in the 2022 results.

CVS Health released its second quarter earnings report Aug. 7, beating analyst predictions as its three businesses reported better-than-expected results, according to CNBC. 1. CVS’ net income grew.

With pharmacy benefit managers industry facing greater calls for transparency, one of the industry's largest players has unveiled a new business model that passes 100% of rebates to plan sponsors. CVS ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. CVS Health anticipates the losses of its pharmacy contract ...

New York Attorney General Letitia James has filed suit against CVS Health, saying the company violated antitrust laws and prevented safety net hospitals from receiving millions in 340B discounts.

CVS is one of the cheapest companies on the market based on simple ratios - its FCF yield is currently 13.6%, and it trades at a 9.0 forward P/E. CVS is also one of the fastest-growing among its peers ...

CVS has transformed its business with significant acquisitions. The stock has a safe dividend, attractive price tag, and potential for growth. Regulatory dangers are a wildcard to monitor. Once a dull ...

New York prosecutors on Thursday accused CVS of diverting millions of dollars from low-income and medically underserved communities in New York as part of a scheme that violated antitrust laws. The ...

As one of the USA’s largest retailers, retail pharmacy CVS is unsurprisingly a leader in retail media in the pharmacy sector, ...